Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Krystal
Activity of the HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068, Against CD4-Independent Viruses and HIV-1 Envelopes Resistant to Other Entry Inhibitors
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Entecavir Exhibits Inhibitory Activity Against Human Immunodeficiency Virus Under Conditions of Reduced Viral Challenge
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Crystal Structures of Trimeric HIV Envelope With Entry Inhibitors BMS-378806 and BMS-626529
Nature Chemical Biology
Cell Biology
Molecular Biology
Synthesis of Betulinic Acid Derivatives as Entry Inhibitors Against HIV-1 and Bevirimat-Resistant HIV-1 Variants
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
P04-40. Dissecting Pre- And Post-Attachment Activity of HIV-1 Entry Inhibitors and Neutralizing Antibodies
Retrovirology
Virology
Infectious Diseases
Broadly Resistant HIV-1 Against CD4-binding Site Neutralizing Antibodies
PLoS Pathogens
Immunology
Molecular Biology
Virology
Microbiology
Parasitology
Genetics
Contribution of Intrinsic Reactivity of the HIV-1 Envelope Glycoproteins to CD4-Independent Infection and Global Inhibitor Sensitivity
PLoS Pathogens
Immunology
Molecular Biology
Virology
Microbiology
Parasitology
Genetics
Template-Constrained Cyclic Sulfopeptide HIV-1 Entry Inhibitors
Organic and Biomolecular Chemistry
Organic Chemistry
Theoretical Chemistry
Biochemistry
Physical
In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Inefficient Entry of Vicriviroc-Resistant HIV-1 via the Inhibitor-Ccr5 Complex at Low Cell Surface CCR5 Densities
Virology
Virology
Design of Potent Inhibitors of HIV-1 Entry From the Gp41 N-Peptide Region
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary